Can the ‘Trust Hormone’ make it as a treatment for schizophrenia and autism?

“He [Martin Shkreli] plans to test the nosespray oxytocin as a schizophrenia drug – Retrophin is also announcing a 100-patient clinical trial testing Syntocinon in the psychiatric disorder – and in autism, where small studies have also showed a glimmer of hope that it might be helpful. But Shkreli says the schizophrenia opportunity comes first. Scientists haven’t even figured out good enough tests to measure autism symptoms, and he is wary of rushing into big clinical tests until he can make progress toward solving those problems.”

To read the full article, follow the link below:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s